Form 4 holding
Executive Chair, Director
Lyra Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 536,966
- Estimated value
- $1,591,460
- Report date
- 18 Mar 2024
- Price
- $2.96
- Ownership
- Direct
Harlan Waksal - Executive Chair, Director at Lyra Therapeutics, Inc.
Issuer-level insider activity
- Role
- Executive Chair, Director
- Issuer ticker
- LYRA on OTC
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Harlan Waksal since 14 Oct 2025
Reported holdings for Harlan Waksal in Lyra Therapeutics, Inc.
Form 4 holding
Executive Chair, Director
Lyra Therapeutics, Inc.
- Security class
- Performance-based Restricted Stock Units
- Shares / value
- 0
- Estimated value
- Report date
- 09 Dec 2024
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Harlan Waksal in Lyra Therapeutics, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.